Cargando…

“Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study”

BACKGROUND: Lung cancer survivors need more options to improve quality of life (QoL). It is unclear to what extent patients with advanced stage disease are willing to participate in home-based physical activity (PA) and if these interventions improve QoL. The goal of our study was to determine inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bade, Brett C., Gan, Geliang, Li, Fangyong, Lu, Lingeng, Tanoue, Lynn, Silvestri, Gerard A., Irwin, Melinda L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015735/ https://www.ncbi.nlm.nih.gov/pubmed/33794808 http://dx.doi.org/10.1186/s12885-021-08084-0

Ejemplares similares

A Patient-Centered Activity Regimen Improves Participation in Physical Activity Interventions in Advanced-Stage Lung Cancer
por: Bade, Brett C., et al.
Publicado: (2018)

Assessing the Correlation Between Physical Activity and Quality of Life in Advanced Lung Cancer
por: Bade, Brett C., et al.
Publicado: (2016)

Lung cancer with air lucency: a systematic review and clinical management guide
por: Detterbeck, Frank C., et al.
Publicado: (2023)

Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer
por: Schernberg, Antoine, et al.
Publicado: (2018)

Strange Bedfellows: The Interaction between COPD and Lung Cancer in the Context of Lung Cancer Screening
por: Silvestri, Gerard A., et al.
Publicado: (2020)

The Role of the Advanced Practitioner in a Comprehensive Lung Cancer Screening and Pulmonary Nodule Program
por: Reid1, Amanda E., et al.
Publicado: (2014)

Molecular biomarkers in early stage lung cancer
por: Rodríguez, María, et al.
Publicado: (2021)

Analysis of lung cancer measures of the National Cancer Network pilot study in Poland for potential improvement in the quality of advanced-stage lung cancer therapy
por: Trembecki, Łukasz, et al.
Publicado: (2021)

Recent advances in early stage lung cancer
por: Luna, Javier, et al.
Publicado: (2021)

Analysis of haemostasis biomarkers in patients with advanced stage lung cancer during hypofractionated radiotherapy treatment
por: Wolny-Rokicka, Edyta, et al.
Publicado: (2018)

Effect of Exercise on Metabolic Syndrome Variables in Breast Cancer Survivors
por: Thomas, Gwendolyn A., et al.
Publicado: (2013)

Randomized trial of exercise on cancer‐related blood biomarkers and survival in women with ovarian cancer
por: Cartmel, Brenda, et al.
Publicado: (2023)

Lung Cancer Proteomics: Recent Advances in Biomarker Discovery
por: Indovina, Paola, et al.
Publicado: (2011)

Biomarker Testing for People With Advanced Lung Cancer in England
por: Adizie, Jana B., et al.
Publicado: (2021)

The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
por: Song, Mengmeng, et al.
Publicado: (2022)

Staging of Lung Cancer
por: Mountain, Clifton F.
Publicado: (1981)

Lung cancer staging
por: Diederich, Stefan, et al.
Publicado: (2015)

Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia
por: HANAFI, Arif R, et al.
Publicado: (2020)

A 62-Year-Old Woman With Lung Cancer, Ulcerating Rash, and Rapidly Progressive Hypoxemia
por: Kunitomo, Yukiko, et al.
Publicado: (2020)

Randomized trial of weight loss on circulating ghrelin levels among breast cancer survivors
por: Puklin, Leah, et al.
Publicado: (2021)

Lung Cancer Screening Rates During the COVID-19 Pandemic
por: Fedewa, Stacey A., et al.
Publicado: (2022)

Advances in radiological staging of non-small cell lung cancer (NSCLC)
por: Rankin, S C
Publicado: (2004)

An update on the role of advanced diagnostic bronchoscopy in the evaluation and staging of lung cancer
por: Belanger, Adam R., et al.
Publicado: (2017)

Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung Cancer
por: Pierret, Thomas, et al.
Publicado: (2020)

Spatial assessment of advanced-stage diagnosis and lung cancer mortality in Brazil
por: de Lima, Kálya Yasmine Nunes, et al.
Publicado: (2022)

Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report
por: Mazzone, Peter J., et al.
Publicado: (2020)

Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report
por: Mazzone, Peter J., et al.
Publicado: (2020)

Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report
por: Mazzone, Peter J., et al.
Publicado: (2020)

Advances in lung cancer
por: Pacheco, Jose M., et al.
Publicado: (2017)

Effect of Shenqi Fuzheng Injection on Leukopenia and T-cell Subsets in Patients with Non-small Cell Lung Cancer Undergoing Radiotherapy
por: Wu, Chengde, et al.
Publicado: (2022)

Impact of Tobacco Dependence in Risk Prediction Models for Lung Cancer Diagnoses and Deaths
por: Ward, Ralph C, et al.
Publicado: (2019)

Circulating and tissue biomarkers in early-stage non-small cell lung cancer
por: Fumagalli, Caterina, et al.
Publicado: (2017)

Biomarkers in Early Diagnosis and Early Stage Lung Cancer: The Clinician’s Point of View
por: Gasparri, Roberto, et al.
Publicado: (2020)

Biomarkers predictive value in early stage non-small cell lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2020)

Microbiota Biomarkers for Lung Cancer
por: Leng, Qixin, et al.
Publicado: (2021)

Salivary Biomarkers in Lung Cancer
por: Skallevold, Hans E., et al.
Publicado: (2021)

Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists
por: Mileham, Kathryn F., et al.
Publicado: (2021)

Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome
por: Lu, Lingeng, et al.
Publicado: (2011)

Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survival
por: Andersen, Barbara L., et al.
Publicado: (2023)

Treatment Outcomes in Elderly with Advanced-Stage Non-small Cell Lung Cancer
por: Tam, Terence Chi-Chun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_igksj4hea2shss7d7qbl2p1q6l